Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening

Por Huang, Y-K, You, S-L, Yuan, C-C, Ke, Y-M, Cao, J-M, Liao, C-Y, Wu, C-H, Hsu, C-S, Huang, K-F, Lu, C-H, Twu, N-F, Chu, T-Y
Publicado em 2008

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries

Por Garland, S M, Pitisuttithum, P, Ngan, H Y S, Cho, C -H, Lee, C -Y, Chen, C -A, Yang, Y C, Chu, T -Y, Twu, N -F, Samakoses, R, Takeuchi, Y, Cheung, T H, Kim, S C, Huang, L -M, Kim, B -G, Kim, Y -T, Kim, K -H, Song, Y -S, Lalwani, S, Kang, J -H, Sakamoto, M, Ryu, H -S, Bhatla, N, Yoshikawa, H, Ellison, M C, Han, S R, Moeller, E, Murata, S, Ritter, M, Sawata, M, Shields, C, Walia, A, Perez, G, Luxembourg, A
Publicado no J Infect Dis (2018)